Table 2 Operation details and pathological and postoperative outcomes of all included patients
From: The taTME learning curve for mid-low rectal cancer: a single-center experience in China
Variable | Values |
|---|---|
Operation details | |
Total operation time, min, median (IQR) | 240 (210–290) |
Intraoperative blood loss, mL, median (IQR) | 100 (50–100) |
Anastomotic technique, n (%) | |
Stapled | 68 (65.4) |
Manual | 26 (25.0) |
Stapled and reinforced by manual | 4 (3.8) |
None | 6 (5.8) |
Stoma creation, n (%) | |
None | 7 (6.7) |
Diverting loop ileostomy | 91 (87.5) |
Permanent colostomy | 6 (5.8) |
Transanal tube use, n (%) | 72 (69.2) |
Conversion to open, n (%) | 2 (1.9) |
Pathology | |
Pathological T stage, n (%) | |
(y)pT0 | 13 (12.5) |
(y)pTis | 3 (2.9) |
(y)pT1 | 13 (12.5) |
(y)pT2 | 25 (24.0) |
(y)pT3 | 49 (47.1) |
(y)pT4 | 1 (1.0) |
Pathological N stage, n (%) | |
(y)pN0 | 76 (73.1) |
(y)pN1 | 20 (19.2) |
(y)pN2 | 8 (7.7) |
Tumor max size, mm, median (IQR) | 30.0 (20.0–42.3) |
Quality of TME specimen, n (%) | |
Complete | 78 (75.0) |
Near complete | 18 (17.3) |
Incomplete | 8 (7.7) |
Circumferential margin involvement, n (%) | 5 (4.8) |
Distal margin involvement, n (%) | 4 (3.8) |
Postoperative outcomes | |
Length of postoperative hospital stay, days, median (IQR) | 7 (6–9) |
Cases with complication(s) within 30 days, n (%) | 39 (37.5) |
Clavien–Dindo I, n (%) | 7 (6.7) |
Clavien–Dindo II, n (%) | 25 (24.0) |
Clavien–Dindo III, n (%) | 4 (3.8) |
Clavien–Dindo IV, n (%) | 3 (2.9) |
Clavien–Dindo V, n (%) | 0 |
Anastomotic leakage, n (%) | 17 (17.3) |
Grade A | 4 (4.1) |
Grade B | 12 (12.2) |
Grade C | 1 (1.0) |
Reoperation, n (%) | 3 (2.9) |
Readmissions within 30 days, n (%) | 8 (7.7) |
Deaths within 30 days, n (%) | 0 |